Civic Intelligence

Saras Cure

990EZ • Fiscal year 2020 • EIN 82-5445706

Jan 01, 2020 to Dec 31, 2020 • Filed on Nov 15, 2021

783 Stiles DriveCharleston, SC 29412

(843) 864-6760

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

65th percentile

0.02x

Higher debt load relative to assets than 65% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

64th percentile

0.02x

Higher debt load relative to revenue than 64% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Net Margin

84th percentile

40%

Higher net margin than 84% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

88th percentile

102%

Faster asset growth than 88% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

70th percentile

6.3%

Faster revenue growth than 70% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Assets

Up

$125,560

Up $63,450 (+102%) from 2019

Net Assets

Up

$123,052

Up $62,967 (+105%) from 2019

Liabilities

Up

$2,508

Up $483 (+24%) from 2019

Revenue

Up

$158,218

Up $9,393 (+6.3%) from 2019

Expenses

Down

$95,251

Down $80,770 (-46%) from 2019

Net Income

Up

$62,967

Up $90,163 (+332%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$150K$100K$50K$0Assets 2018: $87,281Liabilities 2018: $0Net Assets 2018: $87,2812018Assets 2019: $62,110Liabilities 2019: $2,025Net Assets 2019: $60,0852019Assets 2020: $125,560Liabilities 2020: $2,508Net Assets 2020: $123,0522020Assets 2021: $99,408Liabilities 2021: $3,168Net Assets 2021: $96,2402021Assets 2022: $91,017Liabilities 2022: $0Net Assets 2022: $91,0172022Assets 2023: $64,774Liabilities 2023: $57Net Assets 2023: $64,7172023Assets 2024: $51,801Net Assets 2024: $51,8012024

Highlighted filing

2020

Assets$125,560
Liabilities$2,508
Net Assets$123,052

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2018: $140,900Expenses 2018: $53,619Net Income 2018: $87,2812018Revenue 2019: $148,825Expenses 2019: $176,021Net Income 2019: -$27,1962019Revenue 2020: $158,218Expenses 2020: $95,251Net Income 2020: $62,9672020Revenue 2021: $81,170Expenses 2021: $107,983Net Income 2021: -$26,8132021Revenue 2022: $99,906Expenses 2022: $105,129Net Income 2022: -$5,2232022Revenue 2023: $70,362Expenses 2023: $96,662Net Income 2023: -$26,3002023Revenue 2024: $91,784Expenses 2024: $104,700Net Income 2024: -$12,9162024

Highlighted filing

2020

Revenue$158,218
Expenses$95,251
Net Income$62,967
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Nov 15, 2021
Return Version
2020v4.0
Gross Receipts
$158,218
Mission and Program Overview

Mission

The mission of sara's cure is to make clear cell sarcoma survivable through education and scientific research while ensuring all patients and caregivers impacted have a voice and platform to enact change and strive toward the cure.

Program Services

DescriptionGrantsExpenses
SARA'S CURE IS THE ONLY CCS NON-PROFIT IN THE US. THROUGHOUT 2020 WE HAVE CONTINUED FUNDING A REPURPOSED DRUG SCREEN USING MORE THAN 10 CCS CELL LINES WITH 60 DRUGS THAT HAVE BEEN PREVIOUSLY APPROVED BY THE FDA OR ARE IN PHASE 2/3 CLINICAL TRIALS. WE ARE PARTNERED WITH THE NATIONAL ORGANIZATION OF RARE DISORDERS TO COLLECT NATURAL HISTORIES AND OTHER PATIENT INFORMATION FOR USE BY PHYSICIANS AND RESEARCHERS WHICH WILL AID IN CCS DIRECTED RESEARCH. WE CONTINUED TO RAISE AWARENESS IN THE COMMUNITY WITH A VIRTUAL 5K, LIVE FACEBOOK EVENTS AND OTHER ONLINE ONLY EVENTS (DUE TO COVID).-$57,250
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
LENNIE WOODSExecutive DiFT$0--
KELLY ARGRAVES PHDScientific D-$0--
JENAE HELLERBoard Member-$0--
DRU WILLIAMSBoard Member-$0--
DAWN JUDDTreasurer-$0--
DENNY WOODSBoard Member-$0--
NANETTE DETURKBoard Member-$0--
Fundraising, Events, and Gaming

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Special Events$60,999$60,999-$60,999
Total Events$60,999$60,999-$60,999
Filing and Contact Details

Filer

Filer Name
SARA'S CURE
EIN
82-5445706
Phone
8438646760
Address
783 STILES DRIVE, CHARLESTON, SC 29412

Signing Officer

Name
Lennie Woods
Title
Executive Director
Phone
8438646760
Signed
2021-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Hinske & Clarey LLC
Address
109 WAPPOO CREEK DR STE 1A, CHARLESTON, SC 29412-2166
Preparer
Nichole V Hinske CPA
Phone
8437620452
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Special events office 1,245 expenses advertising and website 1,576 marketing materials 12,414 bank & credit card fees 426 supplies 1,429 travel 3,114 total 20,204

Form 990-ez, Part II, Line 24

376 0 TOTAL 376 0

Form 990-ez, Part II, Line 26

CREDIT CARD 2,025 2,508

Form 990-ez, Part III

The mission of sara's cure is to make clear cell sarcoma survivable through education and scientific research while ensuring all patients and caregivers impacted have a voice and platform to enact change and strive toward the cure.

Form 990-ez, Part III, Line 28

Sara's cure is the only ccs non-profit in the us. Throughout 2020 we have continued funding a repurposed drug screen using more than 10 ccs cell lines with 60 drugs that have been previously approved by the fda or are in phase 2/3 clinical trials. We are partnered with the national organization of rare disorders to collect natural histories and other patient information for use by physicians and researchers which will aid in ccs directed research. We continued to raise awareness in the community with a virtual 5k, live facebook events and other online only events (due to covid).

Raw XML Appendix169 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
CompensationExplanation/CompensationExplanationGrp/PersonNm0LENNIE WOODS
CompensationExplanation/CompensationExplanationGrp/PersonNm1KELLY ARGRAVES PHD
CompensationExplanation/CompensationExplanationGrp/PersonNm2JENAE HELLER
CompensationExplanation/CompensationExplanationGrp/PersonNm3DRU WILLIAMS
CompensationExplanation/CompensationExplanationGrp/PersonNm4DAWN JUDD
CompensationExplanation/CompensationExplanationGrp/PersonNm5DENNY WOODS
CompensationExplanation/CompensationExplanationGrp/PersonNm6NANETTE DETURK
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0DAWN JUDD
IRS990EZ/BooksInCareOfDetail/PhoneNum08438646760
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01166 MARINER DRIVE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0CHARLESTON
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0SC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd029412
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt061734
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0125560
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt097218
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt062967
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt070183
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt062110
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0125560
IRS990EZ/FundraisingGrossIncomeAmt060999
IRS990EZ/GrossReceiptsAmt0158218
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt01
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt060085
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0123052
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt060085
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0123052
IRS990EZ/OccupancyRentUtltsAndMaintAmt0874
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt040.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0LENNIE WOODS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1KELLY ARGRAVES PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2JENAE HELLER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DRU WILLIAMS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4DAWN JUDD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5DENNY WOODS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6NANETTE DETURK
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0EXECUTIVE DI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SCIENTIFIC D
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6BOARD MEMBER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0376
IRS990EZ/OtherExpensesTotalAmt020204
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF SARA'S CURE IS TO MAKE CLEAR CELL SARCOMA SURVIVABLE THROUGH EDUCATION AND SCIENTIFIC RESEARCH WHILE ENSURING ALL PATIENTS AND CAREGIVERS IMPACTED HAVE A VOICE AND PLATFORM TO ENACT CHANGE AND STRIVE TOWARD THE CURE.
IRS990EZ/PrintingPublicationsPostageAmt03990
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0SARA'S CURE IS THE ONLY CCS NON-PROFIT IN THE US. THROUGHOUT 2020 WE HAVE CONTINUED FUNDING A REPURPOSED DRUG SCREEN USING MORE THAN 10 CCS CELL LINES WITH 60 DRUGS THAT HAVE BEEN PREVIOUSLY APPROVED BY THE FDA OR ARE IN PHASE 2/3 CLINICAL TRIALS. WE ARE PARTNERED WITH THE NATIONAL ORGANIZATION OF RARE DISORDERS TO COLLECT NATURAL HISTORIES AND OTHER PATIENT INFORMATION FOR USE BY PHYSICIANS AND RESEARCHERS WHICH WILL AID IN CCS DIRECTED RESEARCH. WE CONTINUED TO RAISE AWARENESS IN THE COMMUNITY WITH A VIRTUAL 5K, LIVE FACEBOOK EVENTS AND OTHER ONLINE ONLY EVENTS (DUE TO COVID).
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt057250
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsNetIncomeLossAmt060999
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt02025
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt02508
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt095251
IRS990EZ/TotalProgramServiceExpensesAmt057250
IRS990EZ/TotalRevenueAmt0158218
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.SARASCURE.ORG
IRS990ScheduleA/First5Years509Ind0X
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0OTHER 21,713
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART III, LINE 12
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt097218
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0147312
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0120700
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0365230
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt061000
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt061000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus1YearAmt01513
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus2YearsAmt020200
IRS990ScheduleA/OtherIncome509Grp/TotalAmt021713
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportTotal509Amt0426230
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0158218
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0147312
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0120700
IRS990ScheduleA/Total509Grp/TotalAmt0426230
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0158218
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0148825
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0140900
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0447943
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0SPECIAL EVENTS
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt060999
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt060999
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt060999
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt060999
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt060999
IRS990ScheduleG/FundraisingEventInformationGrp/OtherEventsTotalCnt02
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0SPECIAL EVENTS OFFICE 1,245 EXPENSES ADVERTISING AND WEBSITE 1,576 MARKETING MATERIALS 12,414 BANK & CREDIT CARD FEES 426 SUPPLIES 1,429 TRAVEL 3,114 TOTAL 20,204
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1376 0 TOTAL 376 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2CREDIT CARD 2,025 2,508
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE MISSION OF SARA'S CURE IS TO MAKE CLEAR CELL SARCOMA SURVIVABLE THROUGH EDUCATION AND SCIENTIFIC RESEARCH WHILE ENSURING ALL PATIENTS AND CAREGIVERS IMPACTED HAVE A VOICE AND PLATFORM TO ENACT CHANGE AND STRIVE TOWARD THE CURE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4SARA'S CURE IS THE ONLY CCS NON-PROFIT IN THE US. THROUGHOUT 2020 WE HAVE CONTINUED FUNDING A REPURPOSED DRUG SCREEN USING MORE THAN 10 CCS CELL LINES WITH 60 DRUGS THAT HAVE BEEN PREVIOUSLY APPROVED BY THE FDA OR ARE IN PHASE 2/3 CLINICAL TRIALS. WE ARE PARTNERED WITH THE NATIONAL ORGANIZATION OF RARE DISORDERS TO COLLECT NATURAL HISTORIES AND OTHER PATIENT INFORMATION FOR USE BY PHYSICIANS AND RESEARCHERS WHICH WILL AID IN CCS DIRECTED RESEARCH. WE CONTINUED TO RAISE AWARENESS IN THE COMMUNITY WITH A VIRTUAL 5K, LIVE FACEBOOK EVENTS AND OTHER ONLINE ONLY EVENTS (DUE TO COVID).
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART III, LINE 28
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZTION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DORECTLY OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0LENNIE WOODS
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum08438646760
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0SARA'S CURE
ReturnHeader/Filer/BusinessNameControlTxt0SARA
ReturnHeader/Filer/EIN0825445706
ReturnHeader/Filer/PhoneNum08438646760
ReturnHeader/Filer/USAddress/AddressLine1Txt0783 STILES DRIVE
ReturnHeader/Filer/USAddress/CityNm0CHARLESTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0SC
ReturnHeader/Filer/USAddress/ZIPCd029412
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0271340692
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0HINSKE & CLAREY LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0109 WAPPOO CREEK DR STE 1A
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0CHARLESTON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0SC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0294122166
ReturnHeader/PreparerPersonGrp/PhoneNum08437620452
ReturnHeader/PreparerPersonGrp/PreparationDt02021-11-15
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0NICHOLE V HINSKE CPA
ReturnHeader/ReturnTs02021-11-15T15:01:11-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0LENNIE
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0WOODS
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings